https://www.medscape.com/viewarticle/994717
0
0
7/24/23 at 8:01pm
Organization
Medscape
Final data from the REPRIEVE trial show pitavastatin therapy is associated with a significantly lower risk of cardiovascular events than placebo as evidence grows for statins in primary prevention.
Create an account or login to join the discussion